TITLE

ANATOMY OF AN ECM SOLUTION

PUB. DATE
July 2009
SOURCE
Infonomics;Jul/Aug2009, Vol. 23 Issue 4, p26
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article focuses on the Cephalon Inc., a global biopharmaceutical company based in Frazer, Pennsylvania. Tim Duffy, the company's vice president of information technology and services reveals that their research and development, manufacturing, commercial and financial operations rely on automation and Web-based technologies. Cephalon adopts Enterprise Content Management solutions that enables them to share content in its drug's lifecycle.
ACCESSION #
43638068

 

Related Articles

  • COMPANY SPOTLIGHT -- Cephalon.  // PharmaWatch: Biotechnology;Jun2006, Vol. 5 Issue 6, p32 

    The article focuses on Cephalon Inc., a U.S.-based biopharmaceutical firm which manufactures products used in the treatment of sleep disorders, neurological and psychiatric disorders. The company recorder revenues of about $714.8 million in 2003 and has shown robust performance on almost all...

  • Drug safety alerts move to the Internet.  // Contemporary OB/GYN;Sep2008, Vol. 53 Issue 9, p23 

    The article offers information on the Health Care Notification Network (HCNN), an online network designed to inform physicians of drug safety alerts.

  • Guide to Pharmacology. Singh, Jatinder // Journal of Pharmacology & Pharmacotherapeutics;Jul-Sep2012, Vol. 3 Issue 3, p291 

    The article reviews the web site Guide to Pharmacology, located at http://www.guidetopharmacology.org, from The British Pharmacological Society and the International Union of Basic and Clinical Pharmacology.

  • New Resource For Clinical Trials In Children.  // Child Health Alert;Jan2009, Vol. 27, p4 

    The article offers information on a web site about pediatric medication studies, launched by the U.S. National Institutes of Health (NIH).

  • Members are looking at ...  // Pharmacy Today;Apr2013, Vol. 19 Issue 4, p17 

    The article offers information on APhA DrugInfoLine, an online pharmacotherapy news resources for members of the American Public Health Association (APhA), which offers evidence-based recommendations and drug therapy choices.

  • SIG Consulting prescribes ERP solution for Gilead Sciences. Pritchard, Glyn // Life Science Today;Feb2002, Vol. 3 Issue 1, p24 

    Reports the development and marketing of biopharmaceutical products for the treatment of various infectious disease in Great Britain. Provision of comprehensive information technology consultancy service; Implementation of enterprise resource planning system; Stability of SIG consulting team.

  • COMPANY SPOTLIGHT - COMPANY SPOTLIGHT - Cephalon.  // PharmaWatch: CNS;Mar2008, Vol. 7 Issue 3, p17 

    The article presents a corporate profile for Cephalon Inc., an international biopharmaceutical company engaged in the discovery, development and marketing of products. Its business segments cover the core therapeutics areas which include central nervous system disorders, pain, oncology and...

  • R&D Update.  // PharmaWatch: CNS;Oct2007, Vol. 6 Issue 10, p12 

    The article offers news briefs related to drug research and development in the U.S. Cephalon Inc. reports positive results from a 12-week Phase III clinical trial of Fentora. Akela Pharma Inc. presents promising results from a Phase IIb trial for its pain relief drug candidate Fentanyl Taifun....

  • Regulatory Update.  // PharmaWatch: CNS;Sep2011, Vol. 10 Issue 9, p17 

    The article offers information related to biopharmaceutical industry. It states that the Cephalon Inc. announced that the U.S. Food and Drug Administration (FDA) approved the risk evaluation and mitigation strategy (REMS) for Fentora and Actiq. It mentions that Covidien Ltd. obtained approval...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics